immunotherapy

Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
Claudio Luchini, Robert C Grant, Aldo Scarpa, Steven Gallinger

Gut Oct 2021, 70 (10) 1809-1811; DOI: 10.1136/gutjnl-2020-323805
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
Kate Young, Rita T Lawlor, Chanthirika Ragulan, Yatish Patil, Andrea Mafficini, Samantha Bersani, Davide Antonello, David Mansfield, Sara Cingarlini, Luca Landoni, Antonio Pea, Claudio Luchini, Liliana Piredda, Nagarajan Kannan, Gift Nyamundanda, Daniel Morganstein, Ian Chau, Bertram Wiedenmann, Michele Milella, Alan Melcher, David Cunningham, Naureen Starling, Aldo Scarpa, Anguraj Sadanandam

Gut Oct 2021, 70 (10) 1904-1913; DOI: 10.1136/gutjnl-2020-321016
High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39⁺CD8⁺ T cells
Ting Liu, Jizhou Tan, Minhao Wu, Wenzhe Fan, Jialiang Wei, Bowen Zhu, Jian Guo, Shutong Wang, Penghui Zhou, Hui Zhang, Liangrong Shi, Jiaping Li

Gut Oct 2021, 70 (10) 1965-1977; DOI: 10.1136/gutjnl-2020-322196
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
Anja Rinke, Christoph J Auernhammer, Lisa Bodei, Mark Kidd, Sebastian Krug, Rita Lawlor, Ilaria Marinoni, Aurel Perren, Aldo Scarpa, Halfdan Sorbye, Marianne Ellen Pavel, Matthias M Weber, Irvin Modlin, Thomas M Gress

Gut Sep 2021, 70 (9) 1768-1781; DOI: 10.1136/gutjnl-2020-321300
Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer
Erik S Knudsen, Vishnu Kumarasamy, Sejin Chung, Amanda Ruiz, Paris Vail, Stephanie Tzetzo, Jin Wu, Ram Nambiar, Jared Sivinski, Shailender S Chauhan, Mukund Seshadri, Scott I Abrams, Jianmin Wang, Agnieszka K Witkiewicz

Gut Jan 2021, 70 (1) 127-138; DOI: 10.1136/gutjnl-2020-321000
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
Claudio Luchini, Lodewijk A A Brosens, Laura D Wood, Deyali Chatterjee, Jae Il Shin, Concetta Sciammarella, Giulia Fiadone, Giuseppe Malleo, Roberto Salvia, Valentyna Kryklyva, Maria L Piredda, Liang Cheng, Rita T Lawlor, Volkan Adsay, Aldo Scarpa

Gut Jan 2021, 70 (1) 148-156; DOI: 10.1136/gutjnl-2020-320726
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Matthias Pinter, Bernhard Scheiner, Markus Peck-Radosavljevic

Gut Jan 2021, 70 (1) 204-214; DOI: 10.1136/gutjnl-2020-321702
Braking the cell’s cycle and invigorating T-cell immunity against pancreatic cancer
Gregory B Lesinski

Gut Jan 2021, 70 (1) 4-5; DOI: 10.1136/gutjnl-2020-321497
Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma
Enrico N De Toni, Daniel Roessler

Gut Nov 2020, 69 (11) 2056-2058; DOI: 10.1136/gutjnl-2020-320604
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma
Zhichao Feng, Pengfei Rong, Wei Wang

Gut Oct 2020, 69 (10) 1904-1906; DOI: 10.1136/gutjnl-2019-320116

Main menu

immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

immunotherapy

Pages